CD8A and hepatocellular carcinoma: In addition, miR-24 is upregulated in highly differentiated CD8+ T cells upon etoposide treatment and associated with a decreased DNA damage response [48] and in oral squamous cell carcinomas (OSCC) as compared to their matched controls [49], as well as in hepatocellular carcinomas (HCC), its expression being higher in higher grade HCC [50].